GlaxoSmithKline PLC
LSE:GSK
GlaxoSmithKline PLC
LSE:GSK
Price:
1 705 GBX
1.91%
Market Closed
Updated:
May 2, 2024
GlaxoSmithKline PLC
Net Income (Common)
|
GlaxoSmithKline PLC
Net Income (Common) Peer Comparison
Comparables:
AZN
VRNA
INDV
HIK
DPH
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Net Income (Common)
£4.9B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-1%
|
|
|
AstraZeneca PLC
LSE:AZN
|
Net Income (Common)
$6B
|
CAGR 3-Years
23%
|
CAGR 5-Years
23%
|
CAGR 10-Years
9%
|
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Net Income (Common)
-$54.4m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Indivior PLC
LSE:INDV
|
Net Income (Common)
$2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-63%
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Net Income (Common)
$190m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-1%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Net Income (Common)
-£27.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is GlaxoSmithKline PLC's Net Income (Common)?
Net Income (Common)
4.9B
GBP
4.9B
GBP
Based on the financial report for Dec 31, 2023, GlaxoSmithKline PLC's Net Income (Common) amounts to 4.9B GBP.
What is GlaxoSmithKline PLC's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-1%
-1%
Over the last year, the Net Income (Common) growth was -67%. The average annual Net Income (Common) growth rates for GlaxoSmithKline PLC have been -5% over the past three years , 6% over the past five years , and -1% over the past ten years .
You don't have any saved screeners yet
